Diverticulitis Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Diverticulitis Market is segemented By Treatment (Medical Therapy, Surgical Procedures), By Diagnosis Method (Imaging Tests, Laboratory Tests), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD Billion) for the above-mentioned segments.

Diverticulitis Market is segemented By Treatment (Medical Therapy, Surgical Procedures), By Diagnosis Method (Imaging Tests, Laboratory Tests), By End User (Hospitals, Am ....

Diverticulitis Market Size

Market Size in USD

CAGR7.2%

Study Period	2024 - 2031
Base Year of Estimation	2023
CAGR	7.2%
Market Concentration	Medium
Major Players	Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Allergan (now part of AbbVie), Bayer AG, Johnson & Johnson, Pfizer Inc.

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

Diverticulitis Market Analysis

The diverticulitis market is estimated to be valued at USD 2.68 Bn in 2024 and is expected to reach USD 4.36 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031. The aging population is more prone to develop diverticulitis, as it often occurs in older age groups. This increases the risk of complications associated with the disease.

Diverticulitis Market Report Snapshots

Buy Now